SDS Optic Inc. is a European-based startup with a vision to increase cancer survival rates by 30% by 2030. The company aims to co-create the future of fighting cancer and other serious chronic diseases. Founded in 2013, SDS Optic Inc. operates in the Biotechnology and Medical Devices industries, with its headquarters in Poland.
The company focuses on cutting-edge medical DeepTech, combining molecular biology with photonics technologies, chemistry, and biomedical engineering. Its flagship product, the inPROBE® technology, presents the first-ever In Vivo Photonics Immunoassays platform, potentially revolutionizing healthcare worldwide.
At 21 December 2017, SDS Optic Inc. secured a PLN3.00M Seed Round investment from INNOventure. The company has successfully merged expertise from diverse scientific and business fields, positioning itself at the forefront of innovation in the healthcare industry.
No recent news or press coverage available for SDS Optic Inc..